DEK-NUP214 fusion was associated with an older age (median age 12.6 years versus 8.9 years, p < 0.001), compared to DEK-NUP214 negative AML patients, and the FAB morphology subtype M2 (p = 0.03) [107]. The gene discussed is NUP214; the disease is acute myeloid leukemia.